Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

FDA approves expanded indication for Trelegy Ellipta in COPD

April 25, 2018

Galapagos initiates clinical trial with triple combination therapy in cystic fibrosis

April 25, 2018

Connect Biopharmaceuticals files to begin phase I study of CBP-201 in Australia

April 24, 2018

Novel CFTR modulators divulged by Vertex Pharmaceuticals

April 23, 2018

AdAlta redesigns lead candidate for idiopathic pulmonary fibrosis

April 23, 2018

Medshine Discovery patents MAPK 14 inhibitors

April 20, 2018

Fasenra for asthma now available in Japan

April 19, 2018

Cystic Fibrosis Foundation TDN endorses phase II study protocol for PTI-428

April 19, 2018

New compounds for asthma presented by Sichuan Haisco Pharmaceutical

April 18, 2018

Bayer presents adenosine A2B receptor antagonists and IL-6 release inhibitors

April 16, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Fauci’s silence may put him in contempt of Congress
BioWorld
After repeatedly invoking the Fifth Amendment to every question asked during the July 29 hearing of the U.S. Senate Homeland Security Committee, Anthony Fauci,...